Publicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (17)

2023

  1. Antimicrobial resistance in Gram-negative bacilli in Spain: an experts’ view

    Revista Espanola de Quimioterapia, Vol. 36, Núm. 1, pp. 65-81

  2. Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients

    Intensive Care Medicine, Vol. 49, Núm. 8, pp. 934-945

2022

  1. Interactions listed in the Paxlovid fact sheet, classified according to risks, pharmacological groups, and consequences

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 4, pp. 357-361

  2. Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study

    Intensive Care Medicine, Vol. 48, Núm. 7, pp. 850-864

2021

  1. Correction to: The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients (Critical Care, (2021), 25, 1, (331), 10.1186/s13054-021-03727-x)

    Critical Care

  2. The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients

    Critical Care, Vol. 25, Núm. 1

2020

  1. Recommendations for the diagnosis and treatment of clostridioides difficile infection: An official clinical practice guideline of the spanish society of chemotherapy (SEQ), spanish society of internal medicine (SEMI) and the working group of postoperative infection of the spanish society of anesthesia and reanimation (SEDAR)

    Revista Espanola de Quimioterapia, Vol. 33, Núm. 2, pp. 151-175

2018

  1. Antibiotic selection in the treatment of acute invasive infections by pseudomonas aeruginosa: Guidelines by the Spanish society of chemotherapy

    Revista Espanola de Quimioterapia, Vol. 31, Núm. 1, pp. 78-100

2014

  1. High doses of daptomycin (10 mg/kg/d) plus rifampin for the treatment of staphylococcal prosthetic joint infection managed with implant retention: A comparative study

    Diagnostic Microbiology and Infectious Disease, Vol. 80, Núm. 1, pp. 66-71

2013

  1. [Guidelines for antimicrobial treatment of the infection by Staphylococcus aureus].

    Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia, Vol. 26 Suppl 1, pp. 1-84

2011

  1. New trends in infective endocarditis

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. SUPPL. 4, pp. 22-35

  2. Recomendaciones para el tratamiento de las infecciones f́ngicas invasoras causadas por hongos filamentosos en pacientes hematológicos

    Revista Espanola de Quimioterapia, Vol. 24, Núm. 4, pp. 263-270

2008

  1. Antimicrobial treatment of exacerbation in chronic obstructive pulmonary disease: 2007 Consensus statement

    Archivos de Bronconeumologia, Vol. 44, Núm. 2, pp. 100-108

  2. Guía de tratamiento de la infección producida por Staphylococcus aureus resistente a meticilina

    Revista Espanola de Quimioterapia, Vol. 21, Núm. 4, pp. 234-258

  3. Tratamiento antimicrobiano de la agudización de la EPOC: Documento de Consenso 2007

    Semergen

  4. Update on intra-abdominal and post-surgical infections

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. SUPPL. 3, pp. 22-38

2007

  1. Update on osteo-articular infections and severe skin and soft tissue infections

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 25, Núm. SUPPL. 1, pp. 28-36